FIELD: pharmacology.
SUBSTANCE: antitumor chemical drug is stable nanoparticles in the form of spherical globules 250-400 nm in size. The chemical drug contains doxorubicin as cytostatic in an amount of 20.5-25.3 wt % and dextran-sodium sulfate as a biodegradable polymer - the rest.
EFFECT: increased antitumor activity of the chemical drug.
3 dwg, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
MEDICATION INCREASING ANTITUMOUR EFFECT OF METHOTREXATE | 2009 |
|
RU2411947C1 |
HIGHLY EFFECTIVE METHOD FOR PREPARING DOSAGE FORM OF TARGETED ACTION FOR THERAPY OF MALIGNANT GROWTHS | 2019 |
|
RU2727924C1 |
METHOD OF COMBINED THERAPY FOR CONNECTIVE TISSUE SARCOMA M-1 IN RATS USING A CONJUGATE OF DIPROPOXYBACTERIOPURPURIN WITH DOXORUBICIN | 2023 |
|
RU2808909C1 |
USE OF POLYMERIZED HEMOGLOBIN FOR INCREASING EFFICIENCY OF MALIGNANT TUMOR CHEMOTHERAPY | 2021 |
|
RU2789607C1 |
METHOD OF TREATMENT OF MALIGNANT TUMORS AND COMPOSITION FOR ITS REALIZATION | 1993 |
|
RU2074736C1 |
SPECIFIC COMBINED THERAPY OF MALIGNANT TUMOURS WITH CYTOSTATIC AGENT AND ITS MODIFYING AGENT | 2015 |
|
RU2571551C1 |
AGENT FOR MALIGNANT TUMOR LOCAL TREATMENT | 1992 |
|
RU2083200C1 |
METHODS FOR COMBINED THERAPY OF MALIGNANT NEOPLASMS USING IRON OXIDE NANOPARTICLES | 2023 |
|
RU2816227C1 |
POLYMER CONTAINING MEDICINAL AGENT BASED ON ANTITUMOR AGENT ETOPOSIDE | 2015 |
|
RU2595859C1 |
Authors
Dates
2017-08-30—Published
2016-05-18—Filed